Exchange: OTC·Updated 10:56 AM EDT

RKVTF Rakovina Therapeutics Inc

$0.1538
$0.0178
(13.09%)
Today
Mkt Cap$3.75M
Vol1,200.00

About RKVTF

Rakovina Therapeutics, Inc. focuses on the development of new cancer treatments based on novel DNA-damage response technologies. It engages in developing precision medicines that selectively target and kill cancer cells using science to discover and advance innovative cancer treatments with the potential to improve patient outcomes across multiple tumor types. The company was founded on May 6, 2019 and is headquartered in Vancouver, Canada.
50

Neutral Sentiment

How do you feel about RKVTF?

Advertisement|Remove ads.